Buprenorphine transdermal skin patch and Incruse Ellipta
Determining the interaction of Buprenorphine transdermal skin patch and Incruse Ellipta and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine transdermal skin patch-Indacaterol
- Buprenorphine transdermal skin patch-Indacaterol and Glycopyrrolate
- Buprenorphine transdermal skin patch-Indacaterol and glycopyrrolate Inhalation
- Buprenorphine transdermal skin patch-Indacaterol inhalation
- Buprenorphine transdermal skin patch-Indacaterol Maleate
- Buprenorphine transdermal skin patch-Indapamide
- Incruse Ellipta-Buprenorphine, Buprenorphine Hydrochloride
- Incruse Ellipta-Buprenorphine/naloxone Oromucosal, Sublingual
- Incruse Ellipta-Buproban
- Incruse Ellipta-Bupropion
- Incruse Ellipta-Bupropion and naltrexone
- Incruse Ellipta-Bupropion Extended-Release Tablets